BiotechTube
Home/Rubedo Life Sciences/Matt Gorman, CPA
MG

Matt Gorman, CPA

Chief Financial Officer

Rubedo Life Sciences

Therapeutic Areas

LongevityDermatologyAge-related Diseases

Rubedo Life Sciences Pipeline

DrugIndicationPhase
RLS-1496Actinic KeratosisPhase 1

Leadership Team at Rubedo Life Sciences

DF
Dr. Frederick Beddingfield III
CEO
UL
Uri Lopatin, MD
Investor (Khosla Ventures)
View full Rubedo Life Sciences profile